Management

We’ve assembled a cross-functional management team with proven start-up, scientific, strategic and M&A experience.

JS2_93038507 copy.jpg

COO & President | Kevin Kong, PharmD

  • Biotech investor, e.g Turning Point Therapeutics (20x return)​

  • Operator & Owner of healthcare services companies, including Rosewood Rehab (acquired)​

  • Oncology Research, University of California,​

  • Education: PharmD, University of the Pacific (graduated at age of 21)​

  • Expertise: Clinical Development, Regulatory, Business Development​

  • Industry: Healthcare, Biotechnology, Cosmetics

dinara headshot.jpeg

Director of Chemistry | Dinara Gunasekera, PhD

  • Director of chemistry, Resolute Bio, Inc. 

  • Former senior scientist at Kintai Therapeutics (a Flagship Pioneer company) and Sri Lanka Institute of Nanotechnology  

  • Education: Ph.D, Purdue University, MS University of Minnesota, Duluth. 

  • Expertise: Drug discovery, Nano-medicine,  Synthetic and medicinal chemistry

  • Industry: Healthcare and Biotechnology